Stock & Company Details
Neurocrine Biosciences, Inc. $NBIX
Price:
N/A
N/A
102M
$14B
52 Week High:
N/A
10 Day Average Volume:
N/A
20.71
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
NBIX technical indicators
Latest Neurocrine Biosciences, Inc. (NBIX) indicator readings as of 2026-10-09.
NBIX's 14-day RSI is 41.9, in neutral territory. At $142.44 it is trading 3.3% below its 200-day moving average of $147.23, and below its 50-day average of $151.97. Price sits in the middle of its Bollinger Bands ($134.36 to $153.57). ADX reads 25.0, sitting between trending and range-bound.
NBIX backtested strategy results
How 4 rule-based strategies performed on Neurocrine Biosciences, Inc. (NBIX) over recent history, last backtested 2026-09-06. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +0.9% | 50% | 10 | -41.1% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -4.2% | 31% | 26 | -34.8% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -57.9% | 30% | 30 | -60.4% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +35.4% | 67% | 24 | -34.8% |
Overview
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Finance Bot
Ask your questions
Start by typing a question below.
